3billion

IPO

Ending the diagnostic odyssey for rare disease patients.

3billion was founded in 2016, is headquartered in Seoul, South Korea, lists 51–200 employees, and has $23.0M in recorded funding across 2 rounds.

Headquarters
Seoul
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$23.0M
Last Round
$13.0M Series CJan 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

3billion is a South Korean AI-driven genetic diagnostics company specializing in rare disease testing. Founded in 2016, the company offers comprehensive exome and genome sequencing with unlimited reanalysis — continuously updating results as new diseases are discovered — to reduce the diagnostic odyssey faced by rare disease patients worldwide. Its customers are clinical geneticists, hospital rare disease centers, and patients globally; it has partnered with Seoul National University Hospital and has operations in the United States. 3billion listed on the KOSDAQ exchange in November 2024.

Summary

3billion is an Artificial Intelligence company based in Seoul, South Korea, founded in 2016. It lists 51–200 employees. It has raised $23.0M in total across 2 rounds, most recently a $13.0M Series C round in Jan 2024. Investors include Wells Investment, Korean Development Bank and D3 Jubilee Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPONov 2024
$10.3M

Sign up to see all 3 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

3billion on Indexed.vc
<a href="https://indexed.vc/companies/3billion"><img src="https://indexed.vc/api/badge/company/3billion" alt="3billion on Indexed.vc" width="260" height="76" /></a>